ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

ABUS Arbutus Biopharma Corporation

2.60
0.00 (0.00%)
29 Mar 2024 - Closed
Delayed by 15 minutes

Arbutus Biopharma Financial Summary

The current ABUS market cap is 466.68M. The company's latest EPS is USD -0.4059 and P/E is -6.38.

Quarter End Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 5.95M6.25M6.69M5.01M4.45M
Operating Income -17.81M-22.56M-17.41M-18.66M-21.56M
Net Income -17.57M-21.93M-16.34M-17.09M-20.1M
Year End 31 December 2023 20192020202120222023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 6.01M6.91M10.99M39.02M18.14M
Operating Income -144.07M-57.33M-73.52M-65.46M-78.1M
Net Income -153.72M-75.87M-88.39M-69.46M-72.85M
Quarter End Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Assets 203.8M195.42M191.22M176.82M158.64M
Total Liabilities 58.28M58.57M47.31M42.13M39.3M
Total Equity 145.52M136.85M143.92M134.69M119.34M
Year End 31 December 2023 20192020202120222023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Assets 105.54M137.08M204.49M195.42M144.4M
Total Liabilities 32.79M35.11M35.05M58.57M38.38M
Total Equity 72.74M101.97M169.44M136.85M106.02M
Quarter End Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Operating -18.37M-35.36M-27.3M-46.86M-68.64M
Investing -87.62M-74.94M16.68M18.12M28.55M
Financing 20.73M31.81M20.42M25.16M26.84M
Year End 31 December 2023 20192020202120222023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Operating -71.01M-51.44M-67.53M-35.36M-85.94M
Investing 28.34M-14.91M-12.68M-74.94M50.77M
Financing 37.46M86.75M137.24M31.81M30.65M
Market Cap 466.68M
Price to Earnings Ratio -6.38
Price to Sales Ratio 25.62
Price to Cash Ratio 17.69
Price to Book Ratio 4.38
Dividend Yield -

Share Statistics

Shares Outstanding 179.49M
Average Volume (1 week) 495.38k
Average Volume (1 Month) 647.01k
52 Week Change -15.03%
52 Week High 3.145
52 Week Low 1.69
Spread (Intraday) 0.02 (0.77%)

Company Info

Company Name Arbutus Biopharma Corporation
Address 100
burnaby, british columbia V5J 5J8
Website https://www.tekmirapharm.com
Industry pharmaceutical preparations (2834)

Your Recent History

Delayed Upgrade Clock